Lacosamide UCB Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptika, - lacosamide ucb är indicerat som monoterapi och som tilläggsbehandling vid behandling av partiella anfall med eller utan sekundär generalisering hos vuxna, ungdomar och barn från 4 års ålder med epilepsi.

Lacosamide Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Loperamid Mylan 2 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

loperamid mylan 2 mg kapsel, hård

mylan ab - loperamidhydroklorid - kapsel, hård - 2 mg - loperamidhydroklorid 2 mg aktiv substans; laktosmonohydrat hjälpämne - loperamid

Metoklopramid Alternova 10 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metoklopramid alternova 10 mg filmdragerad tablett

alternova a/s - metoklopramidhydrokloridmonohydrat - filmdragerad tablett - 10 mg - metoklopramidhydrokloridmonohydrat 10,5 mg aktiv substans - metoklopramid

Metoclopramide Orifarm 10 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

metoclopramide orifarm 10 mg tablett

orifarm generics a/s - metoklopramidhydroklorid, vattenfri - tablett - 10 mg - metoklopramidhydroklorid, vattenfri 10 mg aktiv substans; laktosmonohydrat hjälpämne - metoklopramid

Lacosamide Medical Valley 150 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 150 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 150 mg - lakosamid 150 mg aktiv substans

Lacosamide Medical Valley 200 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 200 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 200 mg - lakosamid 200 mg aktiv substans

Lacosamide Medical Valley 100 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 100 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 100 mg - lakosamid 100 mg aktiv substans

Lacosamide Medical Valley 50 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 50 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 50 mg - lakosamid 50 mg aktiv substans

Lacosamide Adroiq Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.